Healthcare Stocks Face Uncertainty and Gridlock as Democrats Prepare to Take Control of Congress

rifanmuazin - Sunday, November 15, 2026 | 12:14
Finance Poetry
Healthcare Stocks Face Uncertainty and Gridlock as Democrats Prepare to Take Control of Congress

Healthcare stocks may struggle to gain sustained momentum in the near term as Democrats prepare to take over Congress, according to industry experts analyzing the shifting political landscape on Capitol Hill.

Jared Holz, who covers the healthcare sector for Mizuho, says that the overall outlook for the industry remains highly uncertain due to the strong likelihood of legislative gridlock between lawmakers in the coming years. With power divided or shifting in Washington, sweeping legislative reforms—whether favored by progressives or conservatives—will likely face steep hurdles to passage.

"The next couple of years I really can’t see too much happening," the firm’s sector specialist told CNBC’s "Fast Money" on Wednesday, offering a cautious assessment of the broader market environment. "I’m not sure you want to own everything, but you can pick and choose the names… Pharma is trading more expensive than tech for the first time in 20 years. So, I backed away from pharma. I would look at medtech."

The cautious sentiment comes despite moments of strong performance across various healthcare segments following recent electoral events. The State Street Health Care Select ETF (XLV) notably jumped 3% a day after Election Day, catching some market participants by surprise given the complex cross-currents affecting the broader equities market.

"You had this very weird situation where typically you wouldn’t have all of these categories work in tandem, and they did. So, I think some things just a little bit off," said Holz, speaking just a day before the healthcare sector got swept up in a broader Wall Street sell-off on Thursday.

Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup

According to Holz, the healthcare sector’s real booster shot may ultimately come further down the road, potentially if a Democrat wins the White House in the 2028 presidential election cycle. A shift in executive leadership could pave the way for policy adjustments that alter the current regulatory and commercial environment for major healthcare corporations, drug manufacturers, and medical device providers.

"Then I think you see some of the Trump strategies rolled back. That’s where I think healthcare could actually perform well," said Holz, who added that such a positive market reaction ultimately hinges on Democrats retaining control of both the Senate and the House of Representatives to enact their preferred policy agenda.

For investors who are currently long on healthcare, Holz emphasized that individual subsectors should not be treated as a monolith and require a highly selective, differentiated approach. Navigating the current regulatory and economic backdrop demands careful stock-picking rather than broad index exposure, especially given rich valuations in certain areas like pharmaceuticals compared to other major market sectors.

"Can we get some of the regulation that has taken place over the past couple of years and overturn that over the near term? I don’t necessarily believe so," Holz said, pointing to the persistent policy overhang affecting drug pricing and institutional oversight. "But if you do, then you probably want to be long some of these medical device stocks that are at or near multi-year lows."

The State Street Health Care Select ETF ultimately ended the week virtually flat, reflecting the tug-of-war between sector-specific optimism and macro-level market volatility. Despite the recent turbulence and anticipation of legislative gridlock, the fund has maintained a solid trajectory over the longer term, rising around 32% since President Trump took office in January 2025. That performance has outpaced the broader S&P 500 index by almost 9 percentage points, highlighting the defensive resilience and steady long-term demand that continue to draw investor interest to the healthcare space even amidst a shifting political backdrop.

Source : Finance Poetry
Author : rifanmuazin
Editor : Finance Poetry Editorial Team